Incyte wins Indian patent injunction just weeks before expiration
By Freny Patel ( November 5, 2026, 07:26 GMT | Insight) -- US biopharma major Incyte secured an Indian injunction against Melody Healthcare just 11 weeks before its ruxolitinib patent’s expiration. The Delhi High Court ruling highlights the availability of interim protection against threatened infringement before a rival’s commercial launch.US biopharma major Incyte Holdings secured an interim injunction against Melody Healthcare over its ruxolitinib patent in India, after a domestic court found that the patent’s remaining validity and the absence of a competing commercial launch favored immediate protection....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.